Search research articles
Contact Us
Filters
Showing results (51-60 of 104) with videos related to
Page
of 11
Sort By:
American Journal of Clinical Oncology
|
April 7, 2020
A Phase 1 Study of SLC-0111, a Novel Inhibitor of Carbonic Anhydrase IX, in Patients With Advanced Solid Tumors
Paul C McDonald, Stephen Chia, Philippe L Bedard, et al.
The Oncologist
|
August 5, 2010
A phase II study of pazopanib in patients with recurrent or metastatic invasive breast carcinoma: a trial of the Princess Margaret Hospital phase II consortium
Sara K Taylor, Stephen Chia, Susan Dent, et al.
Gynecologic Oncology
|
October 21, 2005
Amplification of EMSY, a novel oncogene on 11q13, in high grade ovarian surface epithelial carcinomas
Lindsay A Brown, Julie Irving, Robin Parker, et al.
Iscience
|
April 19, 2020
A Matrilineal Genetic Perspective of Hanging Coffin Custom in Southern China and Northern Thailand
Xiaoming Zhang, Chunmei Li, Yanan Zhou, et al.
Molecular Genetics & Genomic Medicine
|
May 27, 2017
The cost and cost trajectory of whole-genome analysis guiding treatment of patients with advanced cancers
Deirdre Weymann, Janessa Laskin, Robyn Roscoe, et al.
Heliyon
|
December 12, 2022
The clinical impact of COVID-19 on patients with cancer in British Columbia: An observational study
Angela S Mathews, Ashley Paul, Irene S Yu, et al.
Investigational New Drugs
|
November 27, 2007
Phase II study of ispinesib in recurrent or metastatic squamous cell carcinoma of the head and neck
Patricia A Tang, Lillian L Siu, Eric X Chen, et al.
JAMA Oncology
|
February 26, 2016
Association of Pathologic Complete Response to Neoadjuvant Therapy in HER2-Positive Breast Cancer With Long-Term Outcomes: A Meta-Analysis
Kristine R Broglio, Melanie Quintana, Margaret Foster, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 5, 2008
Double-blind, randomized placebo controlled trial of fulvestrant compared with exemestane after prior nonsteroidal aromatase inhibitor therapy in postmenopausal women with hormone receptor-positive, advanced breast cancer: results from EFECT
Stephen Chia, William Gradishar, Louis Mauriac, et al.
Breast Cancer Research and Treatment
|
August 23, 2024
SGLT2 inhibition improves PI3Kα inhibitor-induced hyperglycemia: findings from preclinical animal models and from patients in the BYLieve and SOLAR-1 trials
Manuel Ruiz Borrego, Yen-Shen Lu, Felipe Reyes-Cosmelli, et al.
Page
of 11
Search research articles
Search
Showing results (51-60 of 104) with videos related to
Sort By:
Page
of 11
American Journal of Clinical Oncology
|
April 7, 2020
A Phase 1 Study of SLC-0111, a Novel Inhibitor of Carbonic Anhydrase IX, in Patients With Advanced Solid Tumors
Paul C McDonald, Stephen Chia, Philippe L Bedard, et al.
The Oncologist
|
August 5, 2010
A phase II study of pazopanib in patients with recurrent or metastatic invasive breast carcinoma: a trial of the Princess Margaret Hospital phase II consortium
Sara K Taylor, Stephen Chia, Susan Dent, et al.
Gynecologic Oncology
|
October 21, 2005
Amplification of EMSY, a novel oncogene on 11q13, in high grade ovarian surface epithelial carcinomas
Lindsay A Brown, Julie Irving, Robin Parker, et al.
Iscience
|
April 19, 2020
A Matrilineal Genetic Perspective of Hanging Coffin Custom in Southern China and Northern Thailand
Xiaoming Zhang, Chunmei Li, Yanan Zhou, et al.
Molecular Genetics & Genomic Medicine
|
May 27, 2017
The cost and cost trajectory of whole-genome analysis guiding treatment of patients with advanced cancers
Deirdre Weymann, Janessa Laskin, Robyn Roscoe, et al.
Heliyon
|
December 12, 2022
The clinical impact of COVID-19 on patients with cancer in British Columbia: An observational study
Angela S Mathews, Ashley Paul, Irene S Yu, et al.
Investigational New Drugs
|
November 27, 2007
Phase II study of ispinesib in recurrent or metastatic squamous cell carcinoma of the head and neck
Patricia A Tang, Lillian L Siu, Eric X Chen, et al.
JAMA Oncology
|
February 26, 2016
Association of Pathologic Complete Response to Neoadjuvant Therapy in HER2-Positive Breast Cancer With Long-Term Outcomes: A Meta-Analysis
Kristine R Broglio, Melanie Quintana, Margaret Foster, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 5, 2008
Double-blind, randomized placebo controlled trial of fulvestrant compared with exemestane after prior nonsteroidal aromatase inhibitor therapy in postmenopausal women with hormone receptor-positive, advanced breast cancer: results from EFECT
Stephen Chia, William Gradishar, Louis Mauriac, et al.
Breast Cancer Research and Treatment
|
August 23, 2024
SGLT2 inhibition improves PI3Kα inhibitor-induced hyperglycemia: findings from preclinical animal models and from patients in the BYLieve and SOLAR-1 trials
Manuel Ruiz Borrego, Yen-Shen Lu, Felipe Reyes-Cosmelli, et al.
Page
of 11